![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/20 | (2006.01) |
A61K 9/2027 | (2013.01) | ||
A61K 9/2054 | (2013.01) | ||
A61K 9/2077 | (2013.01) | ||
A61K 31/496 | (2013.01) | ||
A61K 31/519 | (2013.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 43/00 | (2018.01) |
(11) | Number of the document | 3283058 |
(13) | Kind of document | T |
(96) | European patent application number | 16718020.7 |
Date of filing the European patent application | 2016-04-14 | |
(97) | Date of publication of the European application | 2018-02-21 |
(45) | Date of publication and mention of the grant of the patent | 2022-11-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2016/052136 |
Date | 2016-04-14 |
(87) | Number | WO 2016/166703 |
Date | 2016-10-20 |
(30) | Number | Date | Country code |
201562148240 P | 2015-04-16 | US |
(72) |
GURURAJAN, Bindhumadhavan , CH
GRANDEURY, Arnaud , CH
COSTA, Rui , CH
|
(73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | RIBOCICLIB TABLET |
RIBOCICLIB TABLET |